Compare VVOS & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | HTCR |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.4M |
| IPO Year | 2020 | 2022 |
| Metric | VVOS | HTCR |
|---|---|---|
| Price | $0.28 | $2.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 891.3K | 27.3K |
| Earning Date | 04-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 87.84% |
| EPS Growth | 6.76 | ★ 414.29 |
| EPS | ★ N/A | N/A |
| Revenue | $17,443,000.00 | ★ $30,407,229.00 |
| Revenue This Year | $69.66 | $123.26 |
| Revenue Next Year | $48.38 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 16.05 | ★ 39.19 |
| 52 Week Low | $0.26 | $0.15 |
| 52 Week High | $4.93 | $3.97 |
| Indicator | VVOS | HTCR |
|---|---|---|
| Relative Strength Index (RSI) | 35.50 | 46.50 |
| Support Level | N/A | $2.43 |
| Resistance Level | $0.36 | $3.82 |
| Average True Range (ATR) | 0.03 | 0.19 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 14.58 | 31.24 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.